Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
December 29, 2025
Medicare and Medicaid Demos Seek to Impose MFN Pricing: An Overview of GENEROUS, GLOBE, and GUARD
December 22, 2025
EUROPE - Major Regulatory Developments in Pharmaceuticals, Biotechnology, and Medical Devices
January 6, 2026
Former Federal Prosecutor Rebeca Ojeda Rejoins King & Spalding’s Product Liability and Mass Torts Practice as Partner
January 5, 2026
Former federal prosecutor Rebeca Ojeda rejoins the firm’s Product Liability and Mass Torts practice group in Atlanta
December 30, 2025
Will Barnette and Julia Zousmer Elected to The American Law Institute
July 8, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial